ZNF575
gene geneOn this page
Also known as FLJ32567
Summary
ZNF575 (zinc finger protein 575, HGNC:27606) is a protein-coding gene on chromosome 19q13.31, encoding Zinc finger protein 575 (Q86XF7). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 284346 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 52 total
- MANE Select transcript:
NM_174945
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27606 |
| Approved symbol | ZNF575 |
| Name | zinc finger protein 575 |
| Location | 19q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32567 |
| Ensembl gene | ENSG00000176472 |
| Ensembl biotype | protein_coding |
| Entrez | 284346 |
Gene structure
Transcript identifiers
Ensembl transcripts: 26 — 25 protein_coding, 1 retained_intron
ENST00000314228, ENST00000458714, ENST00000598080, ENST00000600154, ENST00000601282, ENST00000880316, ENST00000880317, ENST00000880318, ENST00000880319, ENST00000880320, ENST00000880321, ENST00000880322, ENST00000880323, ENST00000880324, ENST00000880325, ENST00000880326, ENST00000880327, ENST00000880328, ENST00000880329, ENST00000880330, ENST00000880331, ENST00000880332, ENST00000880333, ENST00000880334, ENST00000970960, ENST00000970961
RefSeq mRNA: 2 — MANE Select: NM_174945
NM_001394237, NM_174945
CCDS: CCDS12623
Canonical transcript exons
ENST00000314228 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001290893 | 43533188 | 43533521 |
| ENSE00001311065 | 43533795 | 43533902 |
| ENSE00003061723 | 43535029 | 43536087 |
| ENSE00003530839 | 43534337 | 43534501 |
Expression profiles
Bgee: expression breadth ubiquitous, 157 present calls, max score 87.88.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.3317 / max 32.6671, expressed in 1137 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176196 | 1.6623 | 866 |
| 176195 | 0.6694 | 387 |
Top tissues by expression
232 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 87.88 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.01 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.34 | gold quality |
| colonic mucosa | UBERON:0000317 | 79.52 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 79.01 | silver quality |
| mucosa of sigmoid colon | UBERON:0004993 | 78.44 | silver quality |
| parotid gland | UBERON:0001831 | 78.22 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 77.03 | gold quality |
| transverse colon | UBERON:0001157 | 76.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 75.87 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 75.78 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.74 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 75.50 | gold quality |
| prefrontal cortex | UBERON:0000451 | 75.32 | gold quality |
| primary visual cortex | UBERON:0002436 | 75.20 | gold quality |
| granulocyte | CL:0000094 | 74.77 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 74.28 | gold quality |
| cerebellar cortex | UBERON:0002129 | 74.23 | gold quality |
| right frontal lobe | UBERON:0002810 | 74.16 | gold quality |
| putamen | UBERON:0001874 | 74.09 | gold quality |
| nucleus accumbens | UBERON:0001882 | 73.92 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 73.79 | gold quality |
| frontal cortex | UBERON:0001870 | 73.74 | gold quality |
| colon | UBERON:0001155 | 73.64 | gold quality |
| neocortex | UBERON:0001950 | 73.64 | gold quality |
| cerebellum | UBERON:0002037 | 73.62 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 73.56 | gold quality |
| caudate nucleus | UBERON:0001873 | 73.49 | gold quality |
| large intestine | UBERON:0000059 | 73.48 | gold quality |
| cortical plate | UBERON:0005343 | 73.45 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9543 | yes | 2325.37 |
| E-ANND-3 | no | 2.34 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting ZNF575, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-12117 | 99.50 | 67.57 | 868 |
| HSA-MIR-297 | 99.40 | 69.58 | 1418 |
| HSA-MIR-491-5P | 99.13 | 65.98 | 1468 |
| HSA-MIR-155-3P | 99.03 | 67.99 | 924 |
| HSA-MIR-3926 | 98.95 | 69.26 | 1438 |
| HSA-MIR-548S | 98.50 | 67.17 | 1213 |
| HSA-MIR-595 | 98.25 | 67.44 | 699 |
| HSA-MIR-4659B-5P | 98.03 | 66.84 | 979 |
| HSA-MIR-4659A-5P | 98.03 | 66.42 | 819 |
| HSA-MIR-892B | 98.00 | 67.11 | 821 |
| HSA-MIR-3190-3P | 97.61 | 66.95 | 1406 |
| HSA-MIR-6782-3P | 97.60 | 67.75 | 931 |
| HSA-MIR-939-5P | 97.10 | 65.80 | 1579 |
| HSA-MIR-1343-5P | 96.48 | 66.06 | 1506 |
| HSA-MIR-12115 | 94.19 | 66.37 | 738 |
Literature-anchored findings (GeneRIF, showing 1)
- Results found DNA methylation of the ZNF575 gene in infant cord blood to be associated with maternal antidepressant use in pregnancy in two independent cohorts. This association persists into early childhood. (PMID:30925934)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp575 | ENSMUSG00000066721 |
| rattus_norvegicus | Zfp575 | ENSRNOG00000024065 |
Paralogs (36): ZBTB32 (ENSG00000011590), SNAI2 (ENSG00000019549), PRDM1 (ENSG00000057657), PRDM6 (ENSG00000061455), ZNF76 (ENSG00000065029), PATZ1 (ENSG00000100105), MAZ (ENSG00000103495), ZBTB16 (ENSG00000109906), ZNF451 (ENSG00000112200), ZBTB45 (ENSG00000119574), ZNF410 (ENSG00000119725), SNAI1 (ENSG00000124216), ZNF384 (ENSG00000126746), ZBTB1 (ENSG00000126804), VEZF1 (ENSG00000136451), PRDM14 (ENSG00000147596), ZNF276 (ENSG00000158805), ZNF362 (ENSG00000160094), ZNF653 (ENSG00000161914), ZNF281 (ENSG00000162702), ZNF148 (ENSG00000163848), ZNF143 (ENSG00000166478), HIC2 (ENSG00000169635), PRDM10 (ENSG00000170325), ZNF296 (ENSG00000170684), ZNF692 (ENSG00000171163), HIC1 (ENSG00000177374), ZBTB18 (ENSG00000179456), ZBTB42 (ENSG00000179627), ZBTB20 (ENSG00000181722), ZBTB7C (ENSG00000184828), SNAI3 (ENSG00000185669), ZFP91 (ENSG00000186660), MTF1 (ENSG00000188786), SCRT2 (ENSG00000215397), SCRT1 (ENSG00000261678)
Protein
Protein identifiers
Zinc finger protein 575 — Q86XF7 (reviewed: Q86XF7)
All UniProt accessions (3): Q86XF7, B3KQ07, M0R087
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001381166, NP_777605* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050636 | C2H2-ZF_domain-containing | Family |
Pfam: PF00096
UniProt features (10 total): zinc finger region 6, compositionally biased region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86XF7-F1 | 75.12 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 39 (showing top):
RNGTGGGC_UNKNOWN, TGCGCANK_UNKNOWN, CCCNNGGGAR_OLF1_01, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, AR_Q6, EGR_Q6, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, UBN1_TARGET_GENES, ZFP91_TARGET_GENES, ZNF22_TARGET_GENES, ZNF350_TARGET_GENES, ZNF407_TARGET_GENES, ZNF8_TARGET_GENES, MIR6077, MIR3685
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
338 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF575 | PHLDB3 | Q6NSJ2 | 617 |
| ZNF575 | PRELID3B | Q9Y3B1 | 574 |
| ZNF575 | SLC16A14 | Q7RTX9 | 503 |
| ZNF575 | TEX101 | Q9BY14 | 503 |
| ZNF575 | BLOC1S6 | Q9UL45 | 493 |
| ZNF575 | CMBL | Q96DG6 | 492 |
| ZNF575 | LYPD3 | O95274 | 468 |
| ZNF575 | JOSD1 | Q15040 | 463 |
| ZNF575 | KCNIP3 | Q9Y2W7 | 463 |
| ZNF575 | MALSU1 | Q96EH3 | 460 |
| ZNF575 | UBE2B | P23567 | 453 |
| ZNF575 | ETHE1 | O95571 | 449 |
| ZNF575 | THOC3 | Q96J01 | 429 |
| ZNF575 | RNF208 | Q9H0X6 | 427 |
| ZNF575 | GTPBP4 | Q9BZE4 | 426 |
IntAct
82 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF575 | ZRANB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | SNX33 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNS2 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | ZNF526 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | CARD10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-3 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KHDRBS3 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | MAPK8IP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HAP1 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TP53BP2 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYF5 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPK | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | KRTAP17-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-1 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPRED2 | ZNF575 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF575 | ZRANB1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF575 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF575 | SNX33 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF575 | TNS2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF575 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (26): ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), ZNF575 (Two-hybrid), KRTAP17-1 (Two-hybrid)
ESM2 similar proteins: A6NM28, A8K8V0, P10075, P28698, P30373, Q0VCC5, Q2TA17, Q3US17, Q499Z4, Q4R3I5, Q4R8S8, Q504L7, Q5R4P8, Q5RJR4, Q5U4E2, Q642B2, Q68H95, Q6DD87, Q6ZMY9, Q6ZN55, Q6ZNH5, Q7L3S4, Q7Z7K2, Q80VM4, Q86XF7, Q8BI73, Q8BIF9, Q8BJ90, Q8BKK5, Q8BY46, Q8JZL0, Q8K2R5, Q8NCA9, Q96BV0, Q96C28, Q96CS4, Q96H86, Q96K58, Q96MX3, Q96SL8
Diamond homologs: Q3TXZ1, Q86XF7, Q9GM03
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 25 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 9 | 27.9× | 4e-10 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1022 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:43526199:A:AC | donor_gain | 1.0000 |
| 19:43526200:C:CC | donor_gain | 1.0000 |
| 19:43526657:CAT:C | acceptor_gain | 1.0000 |
| 19:43526195:A:C | donor_gain | 0.9900 |
| 19:43526200:CGAAG:C | donor_gain | 0.9900 |
| 19:43526350:C:CC | acceptor_gain | 0.9900 |
| 19:43526451:T:TA | donor_gain | 0.9900 |
| 19:43526452:C:A | donor_gain | 0.9900 |
| 19:43526510:CTGA:C | donor_loss | 0.9900 |
| 19:43526511:TGA:T | donor_loss | 0.9900 |
| 19:43526512:GACCA:G | donor_loss | 0.9900 |
| 19:43526513:A:C | donor_loss | 0.9900 |
| 19:43526514:CCAG:C | donor_gain | 0.9900 |
| 19:43526660:C:CC | acceptor_gain | 0.9900 |
| 19:43526660:CTG:C | acceptor_loss | 0.9900 |
| 19:43526661:T:A | acceptor_loss | 0.9900 |
| 19:43527099:G:A | donor_gain | 0.9900 |
| 19:43527141:G:C | donor_gain | 0.9900 |
| 19:43533488:G:GT | donor_gain | 0.9900 |
| 19:43534498:GAAG:G | donor_gain | 0.9900 |
| 19:43534499:AAGGT:A | donor_loss | 0.9900 |
| 19:43534500:AG:A | donor_loss | 0.9900 |
| 19:43534501:GG:G | donor_loss | 0.9900 |
| 19:43534502:GTG:G | donor_loss | 0.9900 |
| 19:43526143:C:A | donor_gain | 0.9800 |
| 19:43526346:TTCA:T | acceptor_gain | 0.9800 |
| 19:43526348:CA:C | acceptor_gain | 0.9800 |
| 19:43526513:A:AC | donor_gain | 0.9800 |
| 19:43526514:C:CC | donor_gain | 0.9800 |
| 19:43526541:T:TA | donor_gain | 0.9800 |
AlphaMissense
1573 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:43535163:T:C | F72L | 0.999 |
| 19:43535165:C:A | F72L | 0.999 |
| 19:43535165:C:G | F72L | 0.999 |
| 19:43535247:T:C | F100L | 0.999 |
| 19:43535249:C:A | F100L | 0.999 |
| 19:43535249:C:G | F100L | 0.999 |
| 19:43535331:T:C | F128L | 0.999 |
| 19:43535333:T:A | F128L | 0.999 |
| 19:43535333:T:G | F128L | 0.999 |
| 19:43535360:C:A | H137Q | 0.999 |
| 19:43535360:C:G | H137Q | 0.999 |
| 19:43535415:T:C | F156L | 0.999 |
| 19:43535417:C:A | F156L | 0.999 |
| 19:43535417:C:G | F156L | 0.999 |
| 19:43535505:T:C | F186L | 0.999 |
| 19:43535507:C:A | F186L | 0.999 |
| 19:43535507:C:G | F186L | 0.999 |
| 19:43535190:C:A | H81N | 0.998 |
| 19:43535274:C:A | H109N | 0.998 |
| 19:43535276:C:A | H109Q | 0.998 |
| 19:43535276:C:G | H109Q | 0.998 |
| 19:43535358:C:A | H137N | 0.998 |
| 19:43535442:C:A | H165N | 0.998 |
| 19:43535613:T:C | F222L | 0.998 |
| 19:43535615:T:A | F222L | 0.998 |
| 19:43535615:T:G | F222L | 0.998 |
| 19:43535190:C:G | H81D | 0.997 |
| 19:43535192:C:A | H81Q | 0.997 |
| 19:43535192:C:G | H81Q | 0.997 |
| 19:43535247:T:A | F100I | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000369944 (19:43534869 G>A), RS1000559241 (19:43533554 G>A), RS1001165854 (19:43532591 A>T), RS1001858346 (19:43530310 C>T), RS1001890979 (19:43533344 G>A), RS1001991347 (19:43536226 A>G), RS1002310633 (19:43530604 G>A), RS1002525607 (19:43533142 C>G,T), RS1003041257 (19:43529815 ACT>A), RS1003529461 (19:43534133 C>G,T), RS1003581865 (19:43531959 T>C), RS1003963865 (19:43534294 A>G), RS1004055593 (19:43535967 A>G), RS1004071666 (19:43533855 G>A), RS1004266629 (19:43531355 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| pirinixic acid | affects binding, increases activity, increases expression | 1 |
| sodium arsenite | decreases methylation, increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Pantothenic Acid | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.